UNSPSC 51286905: Mequidox

This classification denotes a topical anti-infective agent with the molecular formula C10H10N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4UV6363I81, chemically known as 3-methyl-2-quinoxalinylmethanol n(sup1),n(sup4)-dioxide but more generally known as mequidox, which bears US NIH Compound Identifier 28143. European Medicines Agency schedules Mequidox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08763MIG.

The term MEQUIDOX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). MEQUIDOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=C([N+](=O)C2=CC=CC=C2N1[O-])CO.

UNSPSC 51286905 Mequidox, a Commodity code, covers pharmaceutical products and medical supplies that state and local governments procure for emergency response, public health, and community health initiatives. Recent solicitations show purchasing activity centered on naloxone and drug deactivation systems for community health programs, generic pharmaceuticals and over-the-counter products distributed through multi-state cooperative purchasing frameworks, and medical and first aid supplies for emergency responders. The issuing bodies span county health departments, state health and human services agencies using cooperative purchasing vehicles, and municipal fire departments, reflecting a diverse base of public-health-oriented procurement across jurisdictions of varying size.

Activity appears concentrated in Florida and Minnesota, with Texas involvement in exploratory vendor-capability solicitations. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026 and an estimated contract value of approximately $700,000 in associated purchasing across participating state and local entities. The City of Tampa issued IFB 26P00145 on March 25, 2026, for medical and first aid supplies supporting the Tampa Fire Department Rescue Division, with 169 line items and a $700,000 estimated contract amount, designated as a sheltered market opportunity for certified Small Local Business Enterprises. Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs, signaling potential future competitive activity in pharmaceutical distribution channels.